Literature DB >> 23846497

Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice.

Erin M Foley1,2, Philip L S M Gordts1, Kristin I Stanford1, Jon C Gonzales1,2, Roger Lawrence1, Nicole Stoddard1,2, Jeffrey D Esko1,2.   

Abstract

OBJECTIVE: Chylomicron and very low-density lipoprotein remnants are cleared from the circulation in the liver by heparan sulfate proteoglycan (HSPG) receptors (syndecan-1), the low-density lipoprotein receptor (LDLR), and LDLR-related protein-1 (LRP1), but the relative contribution of each class of receptors under different dietary conditions remains unclear. APPROACH AND
RESULTS: Triglyceride-rich lipoprotein clearance was measured in AlbCre(+)Ndst1(f/f), Ldlr(-/-), and AlbCre(+)Lrp1(f/f) mice and mice containing combinations of these mutations. Triglyceride measurements in single and double mutant mice showed that HSPGs and LDLR dominate clearance under fasting conditions and postprandial conditions, but LRP1 contributes significantly when LDLR is absent. Mice lacking hepatic expression of all 3 receptors (AlbCre(+)Ndst1(f/f) Lrp1(f/f) Ldlr(-/-)) displayed dramatic hyperlipidemia (870 ± 270 mg triglyceride/dL; 1300 ± 350 mg of total cholesterol/dL) and exhibited persistent elevated postprandial triglyceride levels because of reduced hepatic clearance. Analysis of the particles accumulating in mutants showed that HSPGs preferentially clear a subset of small triglyceride-rich lipoproteins (≈ 20-40 nm diameter), whereas LDLR and LRP1 clear larger particles (≈ 40-60 nm diameter). Finally, we show that HSPGs play a major role in clearance of triglyceride-rich lipoproteins in mice fed normal chow or under postprandial conditions but seem to play a less significant role on a high-fat diet.
CONCLUSIONS: These data show that HSPGs, LDLR, and LRP1 clear distinct subsets of particles, that HSPGs work independently of LDLR and LRP1, and that HSPGs, LDLR, and LRP1 are the 3 major hepatic triglyceride-rich lipoprotein clearance receptors in mice.

Entities:  

Keywords:  cholesterol; heparan sulfate proteoglycans; lipoproteins; low-density lipoprotein receptor; low-density lipoprotein receptor–related protein-1; syndecan-1; triglycerides

Mesh:

Substances:

Year:  2013        PMID: 23846497      PMCID: PMC3821931          DOI: 10.1161/ATVBAHA.113.301637

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  42 in total

1.  Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.

Authors:  Jennifer M MacArthur; Joseph R Bishop; Kristin I Stanford; Lianchun Wang; André Bensadoun; Joseph L Witztum; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing.

Authors:  Robert W Mahley; Yadong Huang
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants.

Authors:  A Rohlmann; M Gotthardt; R E Hammer; J Herz
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

Review 4.  Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism.

Authors:  K J Williams; I V Fuki
Journal:  Curr Opin Lipidol       Date:  1997-10       Impact factor: 4.776

5.  Triglyceride-rich lipoprotein metabolism in unique VLDL receptor, LDL receptor, and LRP triple-deficient mice.

Authors:  Sonia M S Espirito Santo; Patrick C N Rensen; Jeltje R Goudriaan; André Bensadoun; Niels Bovenschen; Peter J Voshol; Louis M Havekes; Bart J M van Vlijmen
Journal:  J Lipid Res       Date:  2005-03-16       Impact factor: 5.922

6.  Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo.

Authors:  P C Rensen; N Herijgers; M H Netscher; S C Meskers; M van Eck; T J van Berkel
Journal:  J Lipid Res       Date:  1997-06       Impact factor: 5.922

7.  Heparan sulfate proteoglycans participate in hepatic lipaseand apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins.

Authors:  Z S Ji; H L Dichek; R D Miranda; R W Mahley
Journal:  J Biol Chem       Date:  1997-12-12       Impact factor: 5.157

8.  Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both.

Authors:  S Ishibashi; S Perrey; Z Chen; J i Osuga; M Shimada; K Ohashi; K Harada; Y Yazaki; N Yamada
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

Review 9.  Hypertriglyceridemia: its etiology, effects and treatment.

Authors:  George Yuan; Khalid Z Al-Shali; Robert A Hegele
Journal:  CMAJ       Date:  2007-04-10       Impact factor: 8.262

10.  Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu).

Authors:  W A Mann; P Lohse; R E Gregg; R Ronan; J M Hoeg; L A Zech; H B Brewer
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

View more
  33 in total

1.  Serglycin protects against high fat diet-induced increase in serum LDL in mice.

Authors:  Astri J Meen; Christian A Drevon; Gunnar Pejler; Trond G Jenssen; Ole Kristoffer Olstad; Magnus Åbrink; Svein O Kolset
Journal:  Glycoconj J       Date:  2015-09-21       Impact factor: 2.916

2.  Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans.

Authors:  Hans L Mooij; Sophie J Bernelot Moens; Philip L S M Gordts; Kristin I Stanford; Erin M Foley; Marjolein A W van den Boogert; Julia J Witjes; H Carlijne Hassing; Michael W Tanck; Michiel A J van de Sande; J Han Levels; John J P Kastelein; Erik S G Stroes; Geesje M Dallinga-Thie; Jeff D Esko; Max Nieuwdorp
Journal:  J Lipid Res       Date:  2015-01-07       Impact factor: 5.922

3.  ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.

Authors:  Philip L S M Gordts; Ryan Nock; Ni-Huiping Son; Bastian Ramms; Irene Lew; Jon C Gonzales; Bryan E Thacker; Debapriya Basu; Richard G Lee; Adam E Mullick; Mark J Graham; Ira J Goldberg; Rosanne M Crooke; Joseph L Witztum; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2016-07-11       Impact factor: 14.808

4.  Hepatic entrapment of esterified cholesterol drives continual expansion of whole body sterol pool in lysosomal acid lipase-deficient mice.

Authors:  Amal Aqul; Adam M Lopez; Kenneth S Posey; Anna M Taylor; Joyce J Repa; Dennis K Burns; Stephen D Turley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-08-21       Impact factor: 4.052

Review 5.  Cholesterol and lipoprotein metabolism: Early Career Committee contribution.

Authors:  Hanrui Zhang; Ryan E Temel; Catherine Martel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-09       Impact factor: 8.311

6.  SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr-/- type 1 diabetic mice.

Authors:  Annas Al-Sharea; Andrew J Murphy; L A Huggins; Y Hu; Ira J Goldberg; Prabhakara R Nagareddy
Journal:  Atherosclerosis       Date:  2018-03-02       Impact factor: 5.162

7.  SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus.

Authors:  H Carlijne Hassing; R Preethi Surendran; Bruno Derudas; An Verrijken; Sven M Francque; Hans L Mooij; Sophie J Bernelot Moens; Leen M 't Hart; Giel Nijpels; Jacqueline M Dekker; Kevin Jon Williams; Erik S G Stroes; Luc F Van Gaal; Bart Staels; Max Nieuwdorp; Geesje M Dallinga-Thie
Journal:  Obesity (Silver Spring)       Date:  2014-01-09       Impact factor: 5.002

8.  γ-Secretase Inhibition Lowers Plasma Triglyceride-Rich Lipoproteins by Stabilizing the LDL Receptor.

Authors:  KyeongJin Kim; Ira J Goldberg; Mark J Graham; Meenakshi Sundaram; Enrico Bertaggia; Samuel X Lee; Li Qiang; Rebecca A Haeusler; Daniel Metzger; Pierre Chambon; Zemin Yao; Henry N Ginsberg; Utpal B Pajvani
Journal:  Cell Metab       Date:  2018-03-22       Impact factor: 27.287

9.  High-density lipoproteins are a potential therapeutic target for age-related macular degeneration.

Authors:  Una L Kelly; Daniel Grigsby; Martha A Cady; Michael Landowski; Nikolai P Skiba; Jian Liu; Alan T Remaley; Mikael Klingeborn; Catherine Bowes Rickman
Journal:  J Biol Chem       Date:  2020-07-31       Impact factor: 5.157

10.  Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndrome.

Authors:  A Kolyada; Q Ke; I Karageorgos; P Mahlawat; D A Barrios; P M Kang; N Beglova
Journal:  J Thromb Haemost       Date:  2016-05-03       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.